Zafgen (Zafgen) Total Stockholders Equity : $50.74 Mil (As of Mar. 2020)

View and export this data going back to 2014. Start your Free Trial

What is Zafgen Total Stockholders Equity?

Zafgen's Total Stockholders Equity for the quarter that ended in Mar. 2020 was $50.74 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Zafgen's Book Value per Share for the quarter that ended in Mar. 2020 was $1.35. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Zafgen's Debt-to-Equity for the quarter that ended in Mar. 2020 was 0.41.

Zafgen Total Stockholders Equity Historical Data

The historical data trend for Zafgen's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zafgen Total Stockholders Equity Chart

Zafgen Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Total Stockholders Equity

Get a 7-Day Free Trial

169.11

121.73

78.22

93.27

53.62

Zafgen Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Total Stockholders Equity	Get a 7-Day Free Trial															82.36	72.14	59.88	53.62	50.74

Zafgen (NAS:ZFGN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Zafgen's Book Value per Share for the quarter that ended in Mar. 2020 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(50.742	-	0)	/	37.4696
	=	1.35

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Zafgen's Debt-to-Equity for the quarter that ended in Mar. 2020 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(7.683	+	13.093)	/	50.742
	=	0.41

Zafgen Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zafgen's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zafgen (Zafgen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Center Plaza, Suite 610, Boston, MA, USA, 02108

Website

http://www.zafgen.com

Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.